HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Flexible Contraceptive Ring Lasts for Whole Year

By HospiMedica International staff writers
Posted on 30 Aug 2018
Print article
Image: The Annovera reusable contraceptive ring (Photo courtesy of Hallie Easley / Population Council).
Image: The Annovera reusable contraceptive ring (Photo courtesy of Hallie Easley / Population Council).
A new self-administered hormonal contraceptive formed as a reusable, flexible silicone ring can prevent unwanted pregnancies for up to an entire year.

The Annovera contraceptive ring, developed by the global nonprofit organization Population Council (New York, NY, USA), is a soft, reusable flexible silicone ring (57 mm in diameter) loaded with segesterone acetate and ethinyl estradiol that can be inserted and removed by a woman herself. It is placed vaginally for 21 days and removed for the next seven. When not in use, it is washed and stored in a compact case, withstanding temperatures of up to 30°C, an important consideration for distribution and use in low-resource settings.

Results of the Phase 3 trial, which enrolled a total of 2,308 women across 27 study sites in the United States, Latin America, Europe, and Australia, showed that Annovera was 97.3% effective in preventing pregnancy when used as directed, with a similar risk profile to other combined hormonal contraceptives. Similarly, a boxed warning related to increased cardiovascular risk warns users who smoke. As yet, Annovera has not been adequately evaluated in women with a body mass index (BMI) greater than 29 kg/m2.

“Nearly half of all pregnancies in the United States are unintended, which can increase health risks for mom and baby,” said Julia Bunting, president of the Population Council. “For more than 60 years, the Population Council has been at the vanguard of global efforts to develop innovative family planning methods that meet women’s needs. Having a single contraceptive system that provides a full year of protection while under a woman’s control could be a game-changer for some women.”

Annovera is the sixth contraceptive technology that Population Council researchers have developed to address family planning needs around the world and brought to market through commercialization agreements, which are in use by an estimated 170 million women worldwide. Other contraceptives developed by the Population Council include the copper intrauterine device (IUD) ParaGard; the Mirena intrauterine system; the contraceptive implants Norplant and Jadelle; and Progering, a contraceptive vaginal ring for breastfeeding women.

Related Links:
Population Council

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Anesthesia Workstation
X40

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more